| Original language | English |
|---|---|
| Pages (from-to) | 1534-1543 |
| Number of pages | 10 |
| Journal | Thyroid |
| Volume | 27 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - Dec 2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Austrian Fields of Science 2012
- 301207 Pharmaceutical chemistry
Keywords
- Journal Article
- anaplastic thyroid carcinoma
- gene therapy
- I-131 THERAPY
- sodium-iodide symporter (NIS)
- TARGETED RADIOIODINE THERAPY
- LIVER-CANCER
- ENHANCED PERMEABILITY
- RETINOIC ACID
- radioiodine
- PROSTATE-CANCER
- GENE-THERAPY
- EGFR targeting
- HEPATOCELLULAR CANCER
- SYSTEMIC NONVIRAL DELIVERY
- EXPRESSION
Fingerprint
Dive into the research topics of 'Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver